¥»ºô¯¸¨ì³X¤H¼Æ¡G1011798
¥þ³¡
¡U
ªk«ß
¡U
©R¥O
¡U
¦æ¬F³W«h
¡U
¦æ¬F¨çÄÀ
²Ä 1 / 200 ¶
¤U¤@¶
¢x
³Ì¥½¶
¤½µo¥¬¤é
Ãþ§O
°T®§ºKn
101.05.16
©R¥O
¦æ¬F°|½Ã¥Í¸p¤½§i¡Gq©w¡u¹«~·L¥Íª«¤§ÀËÅç¤èªk¡X¦×¬r±ìµß¤§ÀËÅç¡v¬°¹«~½Ã¥ÍºÞ²zªk©Ò©w¤§¹«~½Ã¥ÍÀËÅç¤èªk¡A¦Û§Y¤é¥Í®Ä
101.05.16
©R¥O
¦æ¬F°|½Ã¥Í¸p¤½§i¡Gq©w¡u¹«~·L¥Íª«¤§ÀËÅç¤èªk¡Ð¸zª¢©·µß¤§ÀËÅç¡v¬°¹«~½Ã¥ÍºÞ²zªk©Ò©w¤§¹«~½Ã¥ÍÀËÅç¤èªk¡A¦Û§Y¤é¥Í®Ä
101.05.16
©R¥O
¦æ¬F°|½Ã¥Í¸p¤½§i¡G¼o¤î¡u¹«~·L¥Íª«¤§ÀËÅç¤èªk¡Ð¦×¬r±ìµß¤Î¨ä¬r¯À¤§ÀËÅç¡v¡B¡u¹«~·L¥Íª«¤§ÀËÅç¤èªk¡Ð¸zª¢©·µß¤§ÀËÅç¡v¡A¦Û§Y¤é¥Í®Ä
101.05.16
©R¥O
¦æ¬F°|½Ã¥Í¸p¤½§i¡G¼o¤î¡u¹«~·L¥Íª«¤§ÀËÅç¤èªk¡Ð¦×¬r±ìµß¤Î¨ä¬r¯À¤§ÀËÅç¡v¡B¡u¹«~·L¥Íª«¤§ÀËÅç¤èªk¡Ð¸zª¢©·µß¤§ÀËÅç¡v¡A¦Û§Y¤é¥Í®Ä
101.05.16
©R¥O
¦æ¬F°|½Ã¥Í¸p¥O¡G×¥¿¡u©I§lªvÀø®vªk¬I¦æ²Ó«h¡v
101.05.15
©R¥O
¦æ¬F°|½Ã¥Í¸p¥O¡Gq©w¡u¤¤ÃĬdÅçµn°O¼f¬d¶O¦¬¶O¼Ð·Ç¡v
101.05.14
©R¥O
¦æ¬F°|½Ã¥Í¸p¥O¡G×¥¿¡u¤ÆùÛ«~§t¦³ÂåÀø©Î¬r¼@ÃÄ«~°ò·Ç¤¤¨¾Åξ¯¦¨¤ÀButyl methoxydibenzoyl methane¤§¨Ï¥Î¶qºÞ²z³W©w¡v¡A¦Û101¦~5¤ë14¤é¥Í®Ä
101.05.11
¦æ¬F³W«h
¦æ¬F°|½Ã¥Í¸p¤¤¥¡°·±d«OÀI§½¥O¡G×¥¿¡u¥þ¥Á°·±d«OÀIÃÄ«~µ¹¥I³W©w¡X²Ä1³¹¯«¸g¨t²ÎÃĪ« Drugs acting on the nervous system 1.3.4.©¬ª÷´Ë¤ó¯gªvÀøÃÄ«~¡vµ¹¥I³W©w¡A¦Û101¦~6¤ë1¤é¥Í®Ä
101.05.10
¦æ¬F³W«h
¦æ¬F°|½Ã¥Í¸p¤¤¥¡°·±d«OÀI§½¥O¡G×¥¿¡u¥þ¥Á°·±d«OÀIÃÄ«~µ¹¥I³W©w¡X²Ä2³¹¤ßŦ¦åºÞ¤ÎµÇŦÃĪ« 2.1.5.1.Dabigatran¡]¦pPradaxa¡^¡v³W©w¡A¦Û101¦~6¤ë1¤é¥Í®Ä
101.05.08
©R¥O
¦æ¬F°|½Ã¥Í¸p¥O¡G×¥¿¡uÃÄ«~¬dÅçµn°O¼f¬d·Ç«h¡v³¡¤À±ø¤å